Coming Off Seroquel Alone

An Essay on the Practitioner Vacuum That Waits for Everyone Who Tries to Leave Psychiatry

A reader wrote to me this week. Her question, in essence:

She knows someone trying to come off Seroquel safely. Does anyone know the deficiencies it might have caused? Are there books or functional doctors who work on that?

She is looking for a functional doctor. Someone to walk her person through the Seroquel taper the way a functional cardiologist walks a patient off statins, or a functional endocrinologist walks a patient off long-term steroids. She wants someone who understands what the drug has done to the body, can identify the depletions, can order the right tests, and can hold the patient’s hand through the worst of it.

That person does not exist. Not as a profession. Not as a network. Not in any country I have looked at.

The Assumption Hidden in the Question

Every other branch of medicine has a parallel network for patients who decide that what they have been prescribed is making them worse. Someone leaving conventional cardiology finds functional cardiologists, integrative GPs, nutritionists, lifestyle medicine doctors, chiropractors, osteopaths, and bodyworkers. The person leaving an oncologist finds clinics in Mexico and Germany, a literature on metabolic therapies, and dozens of practitioners whose practices are built around helping the patient leave the mainstream pathway.

These parallel networks are not perfect. They vary in quality. Some are captured by their own commercial pressures. But they exist. A patient can find them. A patient can book an appointment.

Now try the same exercise for someone on Seroquel. Or for someone six years into a benzodiazepine. Or two decades into an SSRI.

What they find is a peer forum, a free PDF from Denmark, and a book by a British psychiatrist whose own profession ignored the problem until he forced them to look at it. They find a small number of dissident practitioners, most of them retired or semi-retired, with waiting lists measured in months. They find a great many websites. They find almost no doctors.

My reader did not ask a strange question. She asked the normal question. The strangeness is that there is no normal answer.

Support This Work

This work remains free because paid subscribers make it possible. If you find value here, consider joining them.

Paid subscribers get access to all books — including The DMSO Book, The Kitchen Remedies Guide, Chlorine Dioxide, The PSA Trap, Breast Cancer, and more — with 1-2 new books added each month. Plus the Deep Dive Audio Library: 180+ in-depth audio book summaries and discussions.

Pricing Update: The annual subscription moves from $50 AUD to $50 USD on May 1 — the first change in five years. Current paid subscribers keep their existing rate. Free subscribers can lock in the current price by upgrading before May 1.

What the Evidence Says About the Vacuum

The emptiness is documented in plain language by the clinicians who actually do this work.

Peter Breggin, who has been doing psychiatric drug withdrawal work for more than forty years, states it directly. It has become very easy for individuals to find clinicians who will prescribe psychiatric drugs, but it remains very difficult for patients to find help in reducing or withdrawing from them. He attributes this to a lack of peer support and training, which leaves most clinicians uncomfortable even responding to a patient’s request for reduction or withdrawal.¹

Peter Gøtzsche puts it more bluntly. Very few doctors know anything about withdrawal, and many make horrible mistakes. If they taper at all, they do it far too quickly, because the prevailing wisdom treats withdrawal as a problem only with benzodiazepines, and because the few guidelines that exist recommend tapering schedules that are dangerously fast.²

The largest survey of long-term users who tried to discontinue — Ostrow and colleagues, published in Psychiatric Services in 2017 — quantifies the vacuum. Of 250 adults with serious mental illness diagnoses who wanted to stop psychiatric drugs, 71% had been taking them for over nine years. Only 54% met their goal of completely discontinuing. Among those who attempted it, only 45% rated doctors as helpful during withdrawal. Sixteen percent began the process against their doctor’s advice. Twenty-seven percent did not tell their doctor, stopped seeing the doctor, or changed doctors. Self-education and contact with peers who had withdrawn were the most frequently cited sources of help.³

More than a quarter of the people who tried to come off went around their doctor or away from their doctor entirely. They were not helped by the profession that put them on the drug. In many cases they were actively avoided by it.

Gøtzsche documents something worse in Denmark. Researchers there tried to run a withdrawal trial involving patients on antipsychotics. The trial collapsed — not because the drugs failed to come off, but because patients were too frightened to participate. They had been told for so long that they would relapse without their medication that the prospect of stopping was, in itself, destabilising.² The profession had successfully convinced them that leaving was more dangerous than staying.

The Horowitz Exception

Mark Horowitz is a training psychiatrist at the NHS with a PhD in the pharmacology of antidepressants from King’s College London. He was prescribed an antidepressant in medical school. Fifteen years later, he tried to come off it following the standard guidelines his own profession had produced. He was blindsided by withdrawal symptoms so severe they forced him back onto the drug.⁴

Unable to find clinical support, he turned to an online peer community founded by Adele Framer — SurvivingAntidepressants.org — and discovered that the people there had worked out, through years of collective trial and error, what the psychiatric literature did not contain. The dose-response curve for these drugs is hyperbolic, not linear. Halving the dose at each taper step, as the official guidelines recommended, guaranteed a withdrawal crash at the bottom of the curve. The patients had figured it out. The profession had not.⁵

In 2019, Horowitz published this finding with David Taylor in The Lancet Psychiatry.⁵ In 2021, with Joanna Moncrieff, he set up England’s first psychiatric drug deprescribing clinic.⁴ In 2024, he and Taylor published The Maudsley Deprescribing Guidelines — the first clinical textbook on how to come off these drugs written within the British medical establishment.⁶

One clinician. One clinic. One book. For a problem that affects tens of millions of patients across every Western country.

Horowitz’s findings were accommodated only after the peer communities had been telling people the same thing for a decade, and after the evidence became too large to ignore. Joanna Moncrieff, Peter Gøtzsche, Peter Breggin, David Healy, and a small handful of others have done comparable work. They remain isolated. They have no referral network underneath them. They are not training a generation of younger clinicians to replace them.

The vacuum is not the temporary feature of a field that hasn’t yet matured. It is the product of active resistance from within the profession.

Why the Vacuum Is Structural

The parallel practitioner network that exists in cardiology, endocrinology, and oncology exists because those branches of medicine concede, even at their most conventional, that the body can heal. A functional cardiologist can hang a shingle because conventional cardiology admits that diet, exercise, stress, and sleep can reverse heart disease. The door is cracked open. The functional practitioner walks through.

Psychiatry does not open that door. Its official framework holds that the conditions it diagnoses are chronic, lifelong, and biologically driven. The Royal College of Psychiatrists, the American Psychiatric Association, and every major national equivalent tell patients that their “illness” requires long-term management, often lifelong, and that stopping medication invites relapse. The DSM categories are described as diseases. The drugs are described as treatments that correct an underlying dysfunction.

In this framework, no role exists for a practitioner who helps people leave. A practitioner who helps people leave is, by definition, someone who believes the drugs were not necessary in the first place, or are no longer necessary, or are causing more harm than the original distress. That practitioner is a heretic within the profession. Not a specialist filling a niche. A threat to the diagnostic framework itself.

The vacuum is not a gap in a functioning system. It is the absence that the system requires in order to continue functioning.

If the profession built a deprescribing subspecialty — trained practitioners, published guidelines, referral pathways, insurance codes — it would be admitting that a significant fraction of its patients never needed the drugs, were harmed by them, and can and should come off them. That admission would collapse the commercial and intellectual scaffolding of the field. The admission is not made. The subspecialty is not built. The patients are left to find their own way.

Gøtzsche puts it in one sentence. It seems, he writes, as if lifelong medication is tacitly assumed to be a good thing.² That is the explanation for the vacuum.

What the Reader Is Actually Asking For

When I translate my reader’s question into what it would take to answer it, the practitioner she is looking for would need to

• understand what Seroquel has done to the body,

• design a hyperbolic taper matched to this patient’s half-life and receptor profile,

• order compounded doses or guide the making of them,

• address the depletions that accumulate during years of antipsychotic exposure,

• manage the return of sleep disruption, anxiety, and emotional intensity that follows removal of the drug,

• and walk alongside for the twelve to thirty-six months this typically takes.

This is a real job. It is a needed job. It is nobody’s job.

No medical school trains for it. No residency offers it. No insurance code reimburses it. No malpractice carrier covers a psychiatrist who specialises in getting people off psychiatric drugs. No prescriber can build a practice around it without accepting the isolation and reduced income that come with practising outside the standard framework. No primary care doctor has the time, the knowledge, or the institutional cover to do it either.

The work exists. The workers do not.

The Reframe: This Was Never a Psychiatric Problem

The practitioner my reader is looking for does not exist because psychiatric drug recovery is not a psychiatric problem. The body’s task, once the drug is tapered off, is not a psychiatric task. It is a terrain task.

The drug was a toxic exposure — a sustained, daily, years-long exposure acting on a nervous system that was probably already carrying some combination of nutritional deficiency, accumulated toxic burden, disrupted sleep, chronic stress, and environmental insult before the prescription was ever written. Years of Seroquel add to that burden. They deplete the body in predictable ways: oxidative stress that consumes glutathione and antioxidant enzymes,⁷ mitochondrial damage, metabolic disruption producing weight gain, blood sugar dysregulation, and elevated lipids,⁸ and a cascade of effects on movement, cognition, and sleep architecture.

What the body needs, once the drug is being reduced, is not correction by a psychiatric specialist. It is removal of the toxic input and restoration of the conditions that allow repair — clean water, nutrient-dense food, mineral repletion, sunlight, sleep, movement, reduction of other ongoing toxic and stress inputs, and time.

The practitioners who support that work do exist. They are simply not labelled as psychiatric practitioners, because the work is not psychiatric. They are the terrain-oriented doctors, the New Biology practitioners, the functional medicine clinicians who understand mitochondrial recovery and mineral repletion, the nutritionists who work with detoxification, the bodyworkers who address the fascia and the lymph.

My reader asked whether there were functional doctors “on that topic.” The honest answer is that the topic, correctly named, is not psychiatric drug withdrawal. The topic is terrain restoration after a prolonged toxic exposure. That has practitioners. Those are the practitioners she needs.

The psychiatric part of the work — writing the taper prescription, adjusting compounded doses — is the smallest part, and it requires the least expertise. Any honest prescriber willing to listen to the patient and read the Horowitz guidelines can do it. The rest of the work, the terrain work, is what actually determines whether recovery happens.

A Practical Map

For my reader, and for anyone in her position, here is what the road actually looks like.

For the taper itself. Horowitz and Taylor’s Maudsley Deprescribing Guidelines is the single most important book.⁶ Breggin’s Psychiatric Drug Withdrawal covers the clinical management in detail, including a case involving Seroquel.¹ Gøtzsche’s Mental Health Survival Kit and Withdrawal from Psychiatric Drugs is plain-language and principles-based.² Sørensen, Rüdinger, Gøtzsche and Toft’s A Practical Guide to Slow Psychiatric Drug Withdrawal is free as a PDF from deadly-medicines.dk.⁹ These four texts contain most of what is known.

For the prescriber. You are probably looking for any doctor — primary care, psychiatrist, or integrative — willing to write the taper according to the schedule you bring them. You are not looking for the prescriber to design it. You are looking for them not to obstruct it. This is a much smaller ask, and much more achievable, than finding a specialist. Compounding pharmacies produce the small custom doses that manufactured pills cannot.

For the peer community. SurvivingAntidepressants.org is the largest and most rigorous. Benzo Buddies covers the benzodiazepine side. Mad in America (madinamerica.com) hosts an enormous archive of first-person accounts, research summaries, and practitioner interviews. The International Institute for Psychiatric Drug Withdrawal (iipdw.org) and the Inner Compass Initiative (theinnercompass.org) are both worth knowing. Ostrow’s survey found that peer contact and self-education were the two most frequently cited sources of help during withdrawal, rated more useful than doctors.³

For the terrain work. The New Biology Clinic (newbiologyclinic.com), built around the framework of Tom Cowan, Andy Kaufman, and colleagues, addresses the underlying causes that mainstream medicine will not examine. Kelly Brogan’s A Mind of Your Own is written by a psychiatrist who now works from a broadly terrain-compatible orientation and addresses coming off psychiatric drugs directly.¹⁰ Competent functional medicine practitioners who understand mitochondrial recovery, mineral repletion, and the role of ongoing toxic exposures can carry much of the load, though their familiarity with psychiatric drugs specifically will vary.

For the depletions. Long-term antipsychotic exposure is associated with oxidative stress consuming glutathione and related antioxidant systems.⁷ The commonly reported associated depletions, drawing from the broader clinical literature, include coenzyme Q10, magnesium, B vitamins (particularly B12 and folate), vitamin D, zinc, and omega-3 fatty acids. These are worth testing and repleting. They are not a substitute for the terrain work. They are part of it.

None of this replaces the specialist network that does not exist. It is what is actually available, and it is what actually works when people succeed — which many do.

For a Six-Year-Old

Your body knows how to get better. It has always known.

When something is hurting it, the body’s job is to repair. It does this on its own, every day, all the time. It does not need a special doctor to do it.

What it needs is good food, clean water, sleep, sunshine, and time. It needs whatever was hurting it to slowly, carefully, stop being there.

The slowly and carefully part matters. You cannot rip a plaster off a wound that has grown into the skin. You have to loosen it a little at a time, and let the skin heal as you go.

That is the whole of it.

Closing

My reader asked for leads to help someone detox from Seroquel safely, and for functional doctors who work on that topic. I have given her the leads I have. I have also told her that the functional doctors she is looking for, in the form she imagines them, do not exist — and will not exist, because the framework that would need to produce them has structural reasons not to.

The absence of a specialist network is not the absence of a path. The path exists. It is slower and harder than it should be. It requires self-education, peer support, a cooperative prescriber, a terrain-oriented practitioner, and time. Many people walk it. Many get to the other side. Ostrow’s survey of those who succeeded found that 82% were satisfied with their decision.³ Few psychiatric interventions can claim that.

What psychiatry will not provide, the body provides — once the exposure stops and the conditions for repair are restored. The doctor she is looking for does not exist. The recovery she is looking for does.

---

Nothing in this essay is medical advice. It is research and analysis. Anyone reducing or stopping a psychiatric drug should do so with qualified support and adequate time, informed by the texts and communities referenced above.

---

References

1. Breggin, Peter R. Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and Their Families. New York: Springer, 2012.

2. Gøtzsche, Peter C. Mental Health Survival Kit and Withdrawal from Psychiatric Drugs. Ann Arbor: L H Press, 2022.

3. Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M., & Cohen, D. “Discontinuing psychiatric medications: a survey of long-term users.” Psychiatric Services 68 (2017): 1232–8.

4. Horowitz, Mark A. Personal and professional biography. See markhorowitz.org and Simons, P., “Peer-support groups were right, guidelines were wrong: Dr. Mark Horowitz on tapering off antidepressants,” Mad in America, March 20, 2019.

5. Horowitz, Mark A., and David Taylor. “Tapering of SSRI treatment to mitigate withdrawal symptoms.” Lancet Psychiatry 6 (2019): 538–46.

6. Horowitz, Mark, and David M. Taylor. The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs. London: Wiley-Blackwell, 2024.

7. Salim, Samina. “Oxidative Stress and Psychological Disorders.” Current Neuropharmacology 12, no. 2 (2014): 140–147.

8. Lieberman, J. A., et al. “Effectiveness of antipsychotic drugs in patients with chronic schizophrenia” (CATIE study). New England Journal of Medicine 353 (2005): 1209–1223.

9. Sørensen, A., Rüdinger, B., Gøtzsche, P. C., and Toft, B. S. A Practical Guide to Slow Psychiatric Drug Withdrawal. Copenhagen, 2020. Available at deadly-medicines.dk.

10. Brogan, Kelly. A Mind of Your Own: The Truth About Depression and How Women Can Heal Their Bodies to Reclaim Their Lives. New York: HarperCollins, 2016.

11. Gøtzsche, Peter C. Is Psychiatry a Crime Against Humanity? Copenhagen: Institute for Scientific Freedom, 2024.

12. Whitaker, Robert. Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America, 2nd ed. New York: Broadway Paperbacks, 2015.

13. Davies, J., and J. Read. “A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?” Addictive Behaviors 97 (2019): 111–121.